Abstract:
In the absence of treatment, quality of life (QOL) decreases as substance use progresses, but appropriate treatment has proved to improve QOL of substance users. In this regard, several substances have been studied and several questionnaires have been used. Some studies have tried to explain the causes of QOL decrease in substance users. It seems that QOL in substance use is not explained as enough as other somatic and psychiatric conditions. There is a lack of data in this field especially regarding the QOL of substance users from developing countries with different pattern of use. In developing countries, adolescents’ and elderly groups’ Specific QOL measures for substance use are less designed. It is not clear whether QOL of the substance users is associated with poor outcomes such as mortality. Our knowledge is also little regarding the association between the level of drug dependency and severity of substance use with QOL. Moderators, mediators and coping are less studied. QOL is not comprehensively studied in different levels of drug-taking including drug use, misuse and dependency (drug addiction), which have various definitions, and may have different impacts on QOL. Associated variables of QOL and also prediction models are less presented. Substance use, misuse and dependency specific questionnaires are topics which are needed in future research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- HIV:
-
human immunodeficiency virus
- IDUs:
-
injecting drug users
- IDUs:
-
injection drug users
- IDUQOL:
-
injection drug user quality of life scale
- MCS:
-
mental component score
- MMT:
- OTI:
-
opiate treatment index
- PCS:
-
physical component score
- PSSS:
-
perceived social support scale
- QOL:
-
quality of life
- QWB:
-
quality of well-being scale
- SF36:
-
short form 36
- SWLS:
-
satisfaction with life scale
References
Addington-Ha UJ, Kalra L. (2001). BMJ. 322: 1417–1420.
Arday DR, Milton MH, Husten CG, Haffer SC, Wheeless SC, Jones SM, Johnson RE. (2003). Am J Prev Med. 24: 234–241.
Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vazquez JM, Martín-Santos R, Torrens M. (2008). Subst Use Misuse. 43(5): 612–632.
Baker F, Intagliata J. (1982). Eval Program Plann. 5: 69–79.
Bell M, Greig T, Gill P, Whelahan H, Bryson G. (2002). Psychiatr Serv. 53: 63–69.
Brogly S, Mercier C, Bruneau J, Palepu A, Franco E. (2003). Substance Use Misuse. 38: 965–992.
Carretero MD, Burgess AP, Soler P, Soler M, Catalan J. (1996). AIDS. 10: 1699–1705.
Daeppen JB, Krieg MA, Burnand B, Yersin B. (1998). Am J Drug Alcohol Abuse. 24: 685–694.
Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. (2004). Hepatology. 39: 74–80.
Darke S, Hall W, Wodak A, Heather N, Ward J. (1992). Br J Addict. 87: 733–742.
Darke S, Ward J, Hall W, Heather N, Wodak A. (1991). The Opiate Treatment Index (OTI) Researcher’s Manual. Report. National Drug & Alcohol Research Centre, Sydney.
Falck RS, Wang J, Carlson RG, Siegal HA: 2000, Crack-cocaine use and mental health status as defined by the SF-36. Addictive Behaviors 25:579–584.
Hubley AM, Russell LB, Palepu A. (2005). Health Qual Life Outcomes. 3: 43.
Kertesz SG, Larson MJ, Horton NJ, Winter M, Saitz R, Samet JH. (2005). Med Care. 43(6): 574–585.
Koch T. (2000). Soc Sci Med. 51: 419–427.
Kraemer KL, Maisto SA, Conigliaro J, McNeil M, Gordon AJ, Kelley ME. (2002). J Gen Intern Med. 17: 382–386.
Margolese HC, Carlos Negrete J, Tempier R, Gill K. (2006). Schizophr Res. 83(1): 65–75.
McKenna M, Chick J, Buxton M, Howlett H, Patience D, Ritson B. (1996). Alcohol Alcohol. 31: 565–576.
Mendlowicz MV, Stein MB. (2000). Am J Psychiatr.157(5): 669–682.
Metzger DS, O’Brien CP. (1990). Substance abuse: the challenge of assessment. In: Spilker B (ed.) Quality of Life Assessments in Clinical Trials. Raven Press, Ltd., New York, pp. 237–246.
Neuner B, Miller PM, Felsmann B, Weiss-Gerlach E, Neumann T, Wernecke KD, Spies C. (2005). Health Qual Life Outcomes. 3: 77.
Padaiga Z, Subata E, Vanagas G. (2007). Medicina (Kaunas). 43(3): 235–41.
Pitisuttithum P, Choopanya K, Bussaratid V, Vanichseni S, van Griensven F, Phonrat B, Martin M, Vimutsunthorn E, Sangkum U, Kitayaporn D, Tappero JW, Heyward W, Francis D. (2007). J Med Assoc Thai. 90(11): 2442–2448.
Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, Magri N, Martin S, Vazquez JM. (2004). Substance Use Misuse. 39: 1353–1368.
Reid A, Lynskey M, Copeland J. (2000). Aust N Z J Public Health. 24: 596–602.
Richter D, Eikelmann B, Berger K. (2004). Qual Life Res. 13: 907–914.
Russell LB, Hubley AM, Palepu A, Zumbo BD. (2003). J Psychoactive Drugs. 35(4): 497–502.
Maremmani I, Pani PP, Pacini M, Perugi G. (2007). J Subst Abuse Treat. 33(1): 91–98.
Reynolds GL, Fisher DG, Klahn JA, Wood MM. (2003). J Psychoactive Drugs. 35(4): 497–502.
Russell LB, Hubley AM. (2005). Int J Testing. 5: 105–131.
Ryan CF, White JM. (1996). Addiction. 91: 39–45.
Stein MD, Mulvey KP, Plough A, Samet JH. (1998). J Subst Abuse. 10: 75–84.
Stoermer R, Drewe J, Dursteler-Mac Farland KM, Hock C, Mueller-Spahn F, Ladewig D. et al. (2003). Biol Psychiatry. 54(8): 854–861.
te Vaarwerk MJ, Gaal EA. (2001). Eur J Public Health. 11(1): 109–115.
Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J. (1997). Addiction. 92: 707–716.
Volk RJ, Cantor SB, Steinbauer JR, Cass AR. (1997). Alcohol Clin Exp Res. 21: 899–905.
Williamson S, Gossop M, Powis B, Griffiths P, Fountain J, Strang J. (1997). Drug Alcohol Depend. 44(2–3): 87–94.
Wilson D, Parsons J, Wakefield M. (1999). Prev Med. 29: 139–144.
Zhang B, Yang J, Luan R, Zhang Y. et al. (2007). Wei Sheng Yan Jiu. 36(5): 591–595.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Assari, S., Jafari, M. (2010). Quality of Life and Drug Abuse. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_214
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_214
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine